Trial Profile
A prospective trial to evaluate the efficacy and tolerability of asunaprevir/daclatasvir combination therapy in cirrhotic patients with hepatitis C virus genotype 1b infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2016
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 14 Mar 2016 New trial record